5
The Forkhead-associated Domain of NBS1 Is Essential for Nuclear Foci Formation after Irradiation but Not Essential for hRAD50zhMRE11zNBS1 Complex DNA Repair Activity* Received for publication, August 25, 2000, and in revised form, October 17, 2000 Published, JBC Papers in Press, November 2, 2000, DOI 10.1074/jbc.C000578200 Hiroshi Tauchi‡, Junya Kobayashi‡, Ken-ichi Morishima‡, Shinya Matsuura‡, Asako Nakamura‡, Takahiro Shiraishi‡, Emi Ito‡, Debora Masnada§, Domenico Delia§, and Kenshi Komatsu‡From the Department of Radiation Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima 734 – 8553, Japan and §Department of Experimental Oncology, Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milano, Italy NBS1 (p95), the protein responsible for Nijmegen breakage syndrome, shows a weak homology to the yeast Xrs2 protein at the N terminus region, known as the forkhead-associated (FHA) domain and the BRCA1 C terminus domain. The protein interacts with hMRE11 to form a complex with a nuclease activity for initiation of both nonhomologous end joining and homologous re- combination. Here, we show in vivo direct evidence that NBS1 recruits the hMRE11 nuclease complex into the cell nucleus and leads to the formation of foci by utiliz- ing different functions from several domains. The amino acid sequence at 665– 693 on the C terminus of NBS1, where a novel identical sequence with yeast Xrs2 pro- tein was found, is essential for hMRE11 binding. The hMRE11-binding region is necessary for both nuclear localization of the complex and for cellular radiation resistance. On the other hand, the FHA domain regu- lates nuclear foci formation of the multiprotein complex in response to DNA damage but is not essential for nu- clear transportation of the complex and radiation resist- ance. Because the FHA/BRCA1 C terminus domain is widely conserved in eukaryotic nuclear proteins related to the cell cycle, gene regulation, and DNA repair, the foci formation could be associated with many pheno- types of Nijmegen breakage syndrome other than radi- ation sensitivity. NBS1 is a responsible gene for Nijmegen breakage syndrome (NBS), 1 a variant of ataxia-telangiectasia. Disruption of NBS1 in NBS patients leads to hypersensitivity to ionizing radiation, chromosomal instability, and a predisposition to cancer (1–3). NBS1 (p95) protein shows a weak (29%) homology to the yeast (Saccharomyces cerevisiae) Xrs2 protein only in the N terminus regions known as forkhead-associated (FHA) domain and BRCA1 C terminus (BRCT) domain (1–3), which are widely conserved in eukaryotic nuclear proteins related to the cell cycle, gene regulation, or DNA repair (4, 5). The protein is known to interact with hMRE11 to form a complex with a nuclease activity for initiation of both nonhomologous end join- ing and homologous recombination (6, 7). However, the func- tion of most of the NBS1 protein is still not understood, because about 70% of the NBS1 protein on the C terminus end does not show any sequence homology to any known proteins including Xrs2 (1–3). Because the mutations found in NBS patients all occur between codons 220 and 385 of the NBS1 gene (3) and lead to proteins truncated downstream of the FHA/BRCT do- main, the C-terminal half of the protein must be associated with the crucial phenotype of NBS, which may depend on nuclear localization of hMRE11zhRAD50 (2). Recently, we re- ported that expression of the full-length NBS1 protein comple- ments multiple NBS phenotype characteristics such as radia- tion sensitivity, the G 2 checkpoint, and focus formation in nucleus after irradiation (8). These findings enable us to ana- lyze the functional domain of NBS1 using deletion mutants of NBS1 transfected in NBS cells. By this approach, we localized an essential domain at C terminus region of NBS1 for hMRE11 binding. Interestingly, we found that the FHA domain at N terminus of NBS1 is not essential for restoration of radiation resistance of NBS patient cells but is essential for nuclear foci formation after DNA damage by radiation. EXPERIMENTAL PROCEDURES Cloning of Chicken Nbs1 cDNA—A partial fragment of the chicken Nbs1 cDNA was obtained from chicken testis poly(A) RNA by RT-PCR using Pyrobest DNA polymerase (TaKaRa) and degenerate primer sets (59-TACGTNGTNGGNMGNAARAA-39 and 59-ATGARNGCRCADAT- NGTYTT-39). A fragment representing the FHA/BRCT domains was cloned after two sets of PCR reactions, subcloned into a pBluescript® II KS(2) vector (Stratagene), and sequenced. The full-length cDNA was then cloned with the 39- and 59-rapid amplification of cDNA ends method. Plasmid Construction—Construction of the NBS1 expression vector and its transfection into cells were performed as described previously (8). Briefly, NBS1 cDNAs containing C-terminal deletions were ampli- fied by PCR using primers containing BamHI sites and point mutations introducing in-frame termination codons (the forward primer was 59-A- ATATGGATCCTGGACCGATGTGGAAACTGCT-39, and reverse prim- ers were as follows: S744, 59-ATAAGGGGATCCTCAAAAAAGATCAT- CAGCAAGAG-39; S703, 59-TAGATCGGATCCTCAAATGATGTGTGG- AAGTTTTG-39; S670, 59-GCCAGGGATCCTTCAGGAAGTAGAGTTTT- TAATCAC-39; and S590, 59-CCTTGTGGATCCTCAAACATTGACATC- TTCCTC-39) and Pyrobest DNA polymerase (TaKaRa). For construction of FHA or FHA/BRCT deletions, the forward primer was substituted with FE3 (59-TTAATGGGATCCACATGCAGAATGGCTTTTCCCG-39) or BRCT-d (59-TGCTGGATCCTTGTCATGGTATCAGTGAAA-39), and a reverse primer for full-length cDNA (8) was used in the PCR reaction. Amplified cDNA was BamHI-digested and ligated into the BamHI site * This work was supported in part by the Ministry of Education, Science, Sports and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. The nucleotide sequence(s) reported in this paper has been submitted to the GenBank TM /EBI Data Bank with accession number(s) AF230342. To whom correspondence should be addressed. Tel.: 81-82-257- 5809; Fax: 81-82-256-7101; E-mail: [email protected]. 1 The abbreviations used are: NBS, Nijmegen breakage syndrome; FHA, forkhead-associated; BRCT, BRCA1 C terminus; PCR, polymer- ase chain reaction; DMEM, Dulbecco’s modified Eagle’s medium; Gy, gray; BD, binding domain; AD, activating domain; del, deletion. Accelerated Publication THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 276, No. 1, Issue of January 5, pp. 12–15, 2001 © 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. This paper is available on line at http://www.jbc.org 12 by guest on July 23, 2020 http://www.jbc.org/ Downloaded from

Accelerated Publication THE J B C · 2017-04-12 · was detected only when codons 665–693 were present in the construct even when N-terminal FHA/BRCT domains were deleted (Fig

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Accelerated Publication THE J B C · 2017-04-12 · was detected only when codons 665–693 were present in the construct even when N-terminal FHA/BRCT domains were deleted (Fig

The Forkhead-associated Domainof NBS1 Is Essential for NuclearFoci Formation after Irradiationbut Not Essential forhRAD50zhMRE11zNBS1 ComplexDNA Repair Activity*

Received for publication, August 25, 2000, and in revised form,October 17, 2000

Published, JBC Papers in Press, November 2, 2000,DOI 10.1074/jbc.C000578200

Hiroshi Tauchi‡, Junya Kobayashi‡,Ken-ichi Morishima‡, Shinya Matsuura‡,Asako Nakamura‡, Takahiro Shiraishi‡,Emi Ito‡, Debora Masnada§, Domenico Delia§,and Kenshi Komatsu‡¶

From the ‡Department of Radiation Biology,Research Institute for Radiation Biology and Medicine,Hiroshima University, Kasumi 1-2-3, Minami-ku,Hiroshima 734–8553, Japan and §Department ofExperimental Oncology, Istituto Nazionale Tumori,Via G. Venezian 1, 20133 Milano, Italy

NBS1 (p95), the protein responsible for Nijmegenbreakage syndrome, shows a weak homology to theyeast Xrs2 protein at the N terminus region, known asthe forkhead-associated (FHA) domain and the BRCA1 Cterminus domain. The protein interacts with hMRE11 toform a complex with a nuclease activity for initiation ofboth nonhomologous end joining and homologous re-combination. Here, we show in vivo direct evidence thatNBS1 recruits the hMRE11 nuclease complex into thecell nucleus and leads to the formation of foci by utiliz-ing different functions from several domains. The aminoacid sequence at 665–693 on the C terminus of NBS1,where a novel identical sequence with yeast Xrs2 pro-tein was found, is essential for hMRE11 binding. ThehMRE11-binding region is necessary for both nuclearlocalization of the complex and for cellular radiationresistance. On the other hand, the FHA domain regu-lates nuclear foci formation of the multiprotein complexin response to DNA damage but is not essential for nu-clear transportation of the complex and radiation resist-ance. Because the FHA/BRCA1 C terminus domain iswidely conserved in eukaryotic nuclear proteins relatedto the cell cycle, gene regulation, and DNA repair, thefoci formation could be associated with many pheno-types of Nijmegen breakage syndrome other than radi-ation sensitivity.

NBS1 is a responsible gene for Nijmegen breakage syndrome

(NBS),1 a variant of ataxia-telangiectasia. Disruption of NBS1in NBS patients leads to hypersensitivity to ionizing radiation,chromosomal instability, and a predisposition to cancer (1–3).NBS1 (p95) protein shows a weak (29%) homology to the yeast(Saccharomyces cerevisiae) Xrs2 protein only in the N terminusregions known as forkhead-associated (FHA) domain andBRCA1 C terminus (BRCT) domain (1–3), which are widelyconserved in eukaryotic nuclear proteins related to the cellcycle, gene regulation, or DNA repair (4, 5). The protein isknown to interact with hMRE11 to form a complex with anuclease activity for initiation of both nonhomologous end join-ing and homologous recombination (6, 7). However, the func-tion of most of the NBS1 protein is still not understood, becauseabout 70% of the NBS1 protein on the C terminus end does notshow any sequence homology to any known proteins includingXrs2 (1–3). Because the mutations found in NBS patients alloccur between codons 220 and 385 of the NBS1 gene (3) andlead to proteins truncated downstream of the FHA/BRCT do-main, the C-terminal half of the protein must be associatedwith the crucial phenotype of NBS, which may depend onnuclear localization of hMRE11zhRAD50 (2). Recently, we re-ported that expression of the full-length NBS1 protein comple-ments multiple NBS phenotype characteristics such as radia-tion sensitivity, the G2 checkpoint, and focus formation innucleus after irradiation (8). These findings enable us to ana-lyze the functional domain of NBS1 using deletion mutants ofNBS1 transfected in NBS cells. By this approach, we localizedan essential domain at C terminus region of NBS1 for hMRE11binding. Interestingly, we found that the FHA domain at Nterminus of NBS1 is not essential for restoration of radiationresistance of NBS patient cells but is essential for nuclear fociformation after DNA damage by radiation.

EXPERIMENTAL PROCEDURES

Cloning of Chicken Nbs1 cDNA—A partial fragment of the chickenNbs1 cDNA was obtained from chicken testis poly(A) RNA by RT-PCRusing Pyrobest DNA polymerase (TaKaRa) and degenerate primer sets(59-TACGTNGTNGGNMGNAARAA-39 and 59-ATGARNGCRCADAT-NGTYTT-39). A fragment representing the FHA/BRCT domains wascloned after two sets of PCR reactions, subcloned into a pBluescript® IIKS(2) vector (Stratagene), and sequenced. The full-length cDNA wasthen cloned with the 39- and 59-rapid amplification of cDNA endsmethod.

Plasmid Construction—Construction of the NBS1 expression vectorand its transfection into cells were performed as described previously(8). Briefly, NBS1 cDNAs containing C-terminal deletions were ampli-fied by PCR using primers containing BamHI sites and point mutationsintroducing in-frame termination codons (the forward primer was 59-A-ATATGGATCCTGGACCGATGTGGAAACTGCT-39, and reverse prim-ers were as follows: S744, 59-ATAAGGGGATCCTCAAAAAAGATCAT-CAGCAAGAG-39; S703, 59-TAGATCGGATCCTCAAATGATGTGTGG-AAGTTTTG-39; S670, 59-GCCAGGGATCCTTCAGGAAGTAGAGTTTT-TAATCAC-39; and S590, 59-CCTTGTGGATCCTCAAACATTGACATC-TTCCTC-39) and Pyrobest DNA polymerase (TaKaRa). For constructionof FHA or FHA/BRCT deletions, the forward primer was substitutedwith FE3 (59-TTAATGGGATCCACATGCAGAATGGCTTTTCCCG-39)or BRCT-d (59-TGCTGGATCCTTGTCATGGTATCAGTGAAA-39), and areverse primer for full-length cDNA (8) was used in the PCR reaction.Amplified cDNA was BamHI-digested and ligated into the BamHI site

* This work was supported in part by the Ministry of Education,Science, Sports and Culture of Japan. The costs of publication of thisarticle were defrayed in part by the payment of page charges. Thisarticle must therefore be hereby marked “advertisement” in accordancewith 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submittedto the GenBankTM/EBI Data Bank with accession number(s) AF230342.

¶ To whom correspondence should be addressed. Tel.: 81-82-257-5809; Fax: 81-82-256-7101; E-mail: [email protected].

1 The abbreviations used are: NBS, Nijmegen breakage syndrome;FHA, forkhead-associated; BRCT, BRCA1 C terminus; PCR, polymer-ase chain reaction; DMEM, Dulbecco’s modified Eagle’s medium; Gy,gray; BD, binding domain; AD, activating domain; del, deletion.

Accelerated PublicationTHE JOURNAL OF BIOLOGICAL CHEMISTRY

Vol. 276, No. 1, Issue of January 5, pp. 12–15, 2001© 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

Printed in U.S.A.

This paper is available on line at http://www.jbc.org12

by guest on July 23, 2020http://w

ww

.jbc.org/D

ownloaded from

Page 2: Accelerated Publication THE J B C · 2017-04-12 · was detected only when codons 665–693 were present in the construct even when N-terminal FHA/BRCT domains were deleted (Fig

of the pIRES-hyg vector (CLONTECH). The entire cDNA insert wasverified by sequencing.

For construction of yeast two-hybrid vectors, full-length NBS1 cDNAor hMRE11 cDNA was ligated into pAS2–1 (CLONTECH) or into theGAL4-activating domain of pACT2 (CLONTECH). Partial deletion mu-tant plasmids were constructed by PCR using full-length constructs asa template, Pyrobest DNA polymerase (TaKaRa), and oligonucleotides(22–24-mer) designed to make an in-frame deletion. The PCR productswere then self-ligated, and the entire DNA sequence was verified.

Cell Culture and Transfection—GM7166VA7 cells from an NBS pa-tient were used as an NBS cell line. HeLa cells were used as a controlcell line with normal radiation sensitivity. Cell cultures were main-tained in DMEM (Life Technologies, Inc.) supplemented with 10%fetal bovine serum (HyClone). The vectors were transfected intoGM7166VA7 cells by electroporation using a GenePulser (Bio-Rad), andstable transformants were selected by incubation in medium containing200 mg/ml hygromycin B (Wako).

Cell Survival Assay—Exponentially growing cells were trypsinized,re-suspended in DMEM, and sealed in a glass tube. The cells were thenirradiated with 60Co g rays at a dose rate of 1.0 Gy/min. Immediatelyafter irradiation, an appropriate number of cells were plated in DMEMsupplemented with 10% fetal bovine serum and 10% fetal calf serum.After 14 days of incubation, the cells were fixed with ethanol andstained with a 4% Giemsa solution (Katayama Chemical). Survivingfractions were calculated by comparing the number of colonies in theexperimental cells with the number of colonies formed in nonirradiatedcontrol cells.

Western Blotting and Immunofluorescent Staining—Whole-cell ex-tracts (from 2 3 106 cells) were prepared as described (8), and 40 mg oftotal protein was applied to an 8% SDS polyacrylamide gel. Afterelectrophoresis, proteins were transferred to a blotting membrane us-ing an electroblot apparatus (ATTO), and immunoblots were performedas described previously (8).

For immunofluorescent staining, cells grown on a glass slide werefixed with cold methanol for 20 min, rinsed with cold acetone for severalseconds, and then air-dried. The slides were stained as described pre-viously (8). The primary antibodies used were as follows: anti-NBS1 (8),anti-hMRE11 (Novus Biologicals), and anti-hRAD50 (GeneTex). Alexa-488-conjugated anti-rabbit IgG (Molecular Probes) was used for visual-ization of NBS1 or hMRE11. Biotinylated anti-mouse IgG (Vector) andAlexa-488-conjugated streptavidin (Molecular Probes) were used forhRAD50. The 488-nm excited green fluorescence from the Alexa-488dye was visualized with a laser scanning microscope (Olympus).

Yeast Two-hybrid Analysis—Full-length or mutated NBS1 cDNAwas expressed as a fusion protein to a GAL4-DNA-binding domain (BD)from pAS2–1 (CLONTECH) or to a GAL4-activating domain (AD) frompACT2 (CLONTECH). The full-length or mutated NBS1-BD (or -AD)plasmid was transfected into the yeast strain GC-1945 (CLONTECH),along with a full-length hMRE11-AD (or -BD) plasmid. Interactionbetween the expressed proteins was detected by growth on a syntheticdropout (2Leu2Trp2His) plate and by b-galactosidase activity.

RESULTS

To locate the functionally important domain of the NBS1gene involved in the human NBS phenotype, we tried to deter-mine which sequences were conserved in NBS1 in higher eu-karyotes. Cloning and sequencing of the chicken Nbs1 gene canbe very useful for locating a conserved domain, because a lowhomology of the NBS1 amino acid sequence between the hu-man sequence and the chicken sequence has been suggested(2). The amino acid sequence of chicken Nbs1 shows apparenthomology with human and mouse NBS1 (62 and 63% identity,respectively) at the N terminus 360 amino acids, which con-tains both the FHA/BRCT domain and a phosphorylation siteon a serine residue at 278 and 343 (Refs. 9 and 10 and data notshown). There is a region with low homology from 360 to 630(33% identity between chicken and human). Another conservedsequence was observed at the region from 631 to 754 and the Cterminus of the protein (Fig. 1). A novel identical sequence withyeast Xrs2 protein was also found in this small region (Fig. 1).This is consistent with the suggestion that the C-terminal halfof NBS1 may interact with hMRE11 (2). To confirm this, wegenerated various C-terminal deletion mutants of NBS1 andtested their ability to bind to hMRE11 using a yeast two-hybrid

analysis. Significant interaction between NBS1 and hMRE11was detected only when codons 665–693 were present in theconstruct even when N-terminal FHA/BRCT domains weredeleted (Fig. 2). This C-terminal region contains a sequencehighly conserved at codons 682–693 in the chicken, mouse,human NBS1, and yeast Xrs2 proteins, implying that the se-quence might be a critical region for hMRE11 binding.

Because NBS1 is essential for the hMRE11zhRAD50zNBS1complex to express nuclease activity or ATP-dependent DNAunwinding activity (11), the hMRE11-binding domain is prob-ably necessary for the processing of damaged DNA. To assaythe functions of the binding domain in vivo, we subclonedmutant NBS1 constructs into expression vectors (shown in Fig.2) and transfected them into the NBS cell line GM7166VA7. Allof the stable transformants expressed a significant amount ofthe mutant NBS1 protein (Fig. 3a). Although the expression ofmultiple smaller proteins were observed in the N-terminal-deleted mutants (Fig. 3a, FE3 and BRCT-d), the expectedmutant NBS1 proteins in the FE3 and BRCT-d clones were stilldetected in their transformants (Fig. 3a). Because it is knownthat NBS1 directly binds to hMRE11 and indirectly to hRAD50through hMRE11 (2), we tested the ability of mutant NBS1 toform the complex. Full-length and S703 mutant protein, con-taining C-terminal conserved region, were able to form thetriple-protein complex, because they coimmunoprecipitatedwith hRAD50. On the other hand, S590 and S670, in which theC-terminal conserves sequence was deleted, were not able toform the complex (Fig. 3b). The result is consistent with yeasttwo-hybrid experiment (Fig. 2), which demonstrated the essen-tial C-terminal domain for hMRE11 binding at 665–693. Al-though the expected mutant protein from FE3 or BRCT-d wasinvisible in NBS1-blot for hRAD50 precipitates (Fig. 3b), a veryweak signal was detected when the increased amount of theprecipitate was used for analysis (data not shown). Because theexpected FE3 or BRCT-d proteins were accompanied by thedegraded small fragments (Fig. 3a), the N terminus mutantproteins could be unstable. The absence of the N terminusregion of the protein in the FE3 and BRCT-d clones was con-firmed by immunoblotting using antiserum that recognizes theN-terminal end of NBS1 (data not shown). From these results,it appears that the multiple proteins expressed in the FE3 andBRCT-d mutants must contain functional hMRE11-binding do-mains at the C-terminal NBS1 region.

Because restoration of radiation resistance was observedonly when the mutant proteins contained the hMRE11-bindingdomain at C terminus (Fig. 4), this suggests that the hMRE11-binding domain is essential for radiation resistance. This wassupported by finding that del 683–693 mutant lacking Xrs2-identical sequence could not restore radiation resistance (datanot shown). Interestingly, cells transfected with mutant NBS1lacking the FHA domain alone or lacking both the FHA and

FIG. 1. Comparison of amino acid sequence at the C-terminalregion in human, mouse, and chicken NBS1. Identical amino acidsamong three organisms (white on black) and two organisms (outlined)are indicated. A small identical sequence with yeast (S. cerevisiae) Xrs2protein is also shown at 678–694 of human NBS1.

Functional Domains of NBS1 13

by guest on July 23, 2020http://w

ww

.jbc.org/D

ownloaded from

Page 3: Accelerated Publication THE J B C · 2017-04-12 · was detected only when codons 665–693 were present in the construct even when N-terminal FHA/BRCT domains were deleted (Fig

BRCT domains (FE3 and BRCT-d) also became radiation re-sistant to a degree similar to that seen in C-terminal end-deleted mutant (S703 in Fig. 4). These results imply that theFHA/BRCT domain is not essential for restoration of radiationresistance, i.e. for DNA repair.

Subsequently, observations were made to see whether the

various truncated NBS1 proteins could restore the focus for-mation activity of the hRAD50zhMRE11zNBS1 complex in NBScells after irradiation, because it has been reported that this

FIG. 2. NBS1 constructs used in the present study and theirhMRE11 binding activity obtained from yeast two-hybrid anal-ysis. Left, a brief protein structure and designed constructs of NBS1.FHA domain at 24–102, BRCT domain at 108–196, and possible phos-phorylation site at Ser278 or Ser343 residues are indicated. Down arrowsrepresent the mutation position in NBS patients (1–3). Right, thehMRE11 binding activity of various NBS1 constructs by means of yeasttwo-hybrid analysis. The columns NBS1zMRE11 or MRE11zNBS1 rep-resent that NBS1 fused to GAL4-DNA-BD (or NBS1 fused to GAL4-AD)was coexpressed with a full-length hMRE11 fused to AD (or BD) inyeast strain GC-1945 (CLONTECH). b-Galactosidase activities of eachtransfectant are indicated by the following symbols: 11, color changewithin 1 h; 1, color change within 3 h; 2, no color change or weak colorchange over 12 h; U, undetermined. Note that a weak color change forS670-ADzhMRE11-BD (and for del 682–693) was detected after a 24-hincubation. The black box represents the putative domain that is es-sential for hMRE11 binding.

FIG. 3. Expression of NBS1 protein in the NBS1-transfectedcell lines. a, immunoblot analysis of NBS cells (GM7166VA7) andvarious NBS1 transfectants. b, formation of the triple-protein complexin NBS cells or in NBS1-transfected cells. Whole-cell extract was im-munoprecipitated with anti-hRAD50 antibody, and the precipitantswere analyzed by immunoblotting with anti-NBS1 (upper panel) oranti-hMRE11 antibody (lower panel). hMRE11 was always coimmuno-precipitated with hRAD50, because they directly interact each other.NBS1 was coimmunoprecipitated with hRAD50 when the mutant pro-tein contained an hMRE11-binding domain (Full, S703, FE3, andBRCT-d).

FIG. 4. Radiation sensitivity of parental NBS (GM7166VA7)-and NBS1-transfected cells. Exponentially growing cells were ex-posed to 4 Gy of g rays, and survivals were determined by colonyformation. Each point represents mean 6 S.D. from at least five inde-pendent clones with duplicate experiments.

FIG. 5. Localization and ionizing radiation-induced foci for-mation of NBS1, hMRE11, and hRAD50 in NBS cells(GM7166VA7) or in cells transfected with various mutants ofNBS1. Nonirradiated cells (IR2) or cells irradiated with 10 Gy of g rays(IR1) were fixed at 3 h post-treatment, and immunofluorescent stain-ing with anti-NBS1, anti-hMRE11, or anti-hRAD50 antibody was per-formed. For the del 682–693 clone, only hMRE11 localization in nonir-radiated controls is shown with 4,6-diamidino-2-phenylindole counter-staining for identification of nucleus.

FIG. 6. Reduction of hRAD50zhMRE11zNBS1 focus formationby expression of FHA-deleted NBS1. The FE3 construct was trans-fected in HeLa cells, and stable transfectants were cloned. hMRE11 fociformation at 3 h after 10-Gy g irradiation was analyzed by immunoflu-orescent staining using anti-hMRE11 antiserum. At least 150 hMRE11foci-positive cells (.7 foci) were randomly observed under a fluorescentmicroscope, and the numbers of hMRE11 foci per cell were calculated.The values are expressed as mean 6 S.D.

Functional Domains of NBS114

by guest on July 23, 2020http://w

ww

.jbc.org/D

ownloaded from

Page 4: Accelerated Publication THE J B C · 2017-04-12 · was detected only when codons 665–693 were present in the construct even when N-terminal FHA/BRCT domains were deleted (Fig

triple-protein complex forms foci at DNA double-strand breaksin the nucleus after exposure to ionizing radiation (12). Anabsence of hMRE11 and hRAD50 in the nucleus was observedin NBS cells (GM7166VA7), and foci did not form when cellswere irradiated with g rays (Fig. 5, GM7166VA7; see Ref. 2). Incontrast, nuclear localization of NBS1, hMRE11, and hRAD50was detected in NBS cells transfected with full-length NBS1,and foci formation in the nucleus was clearly observed afterirradiation (Fig. 5, 1Full). A mutant of NBS1 containing thehMRE11-binding domain showed nuclear localization ofhMRE11 and hRAD50 (Fig. 5, 1S703, 1FE3, and 1BRCT-d),and the lack of the hMRE11-binding domain in the S670, S590,or the del 682–693 clone resulted in the cytoplasmic localiza-tion of the proteins. Because the cells in the absence of triplecomplex in nuclei (S590, S670, and del 682–693) remainedradiation-sensitive (Fig. 4 and data not shown), these resultssuggest that the nuclear localization of hMRE11 and hRAD50is necessary to restore the radiation resistance. Surprisingly,the FE3 and BRCT-d cells could not form foci in response toDNA damage (Fig. 5, 1IR lanes, 1FE3 and 1BRCT-d) eventhough the triple-protein complex was able to localize in thenucleus. To confirm the inability of nuclear foci formation inFE3 mutant NBS1 protein, we transfected this mutant cDNAinto HeLa cells. Significant reduction of foci formation afterradiation was observed in FE3-expressed HeLa cells, possiblyby dominant negative effects (Fig. 6). This FE3-expressingHeLa cell clone showed no alteration of radiation sensitivity(data not shown), supporting the finding that FHA domain isnot essential for restoration of radiation resistance.

DISCUSSION

NBS1 is reported to be essential for nuclear localization ofhRAD50zhMRE11 complex (2) and to enhance the nucleaseactivity of the complex (7, 11). These observations suggest thefunction of NBS1 as a key regulator of both localization andactivity of the triple-protein complex. We identified the essen-tial region at codons 665–693 of NBS1 for hMRE11 binding.The present results also showed that the FHA/BRCT domain ofNBS1 is essential for nuclear foci formation after DNA damagebut not for cellular survival after irradiation. This is confirmedby evidence that foci formation was repressed in FE3-trans-fected HeLa cells. Zhao et al. (10) reported that the alteration ofthe phosphorylation site at both Ser273 and Ser343 residuesmarkedly reduced the foci formation and radiation resistance,suggesting phosphorylation of NBS1 is necessary for both fociformation and DNA repair after irradiation. It is consistentwith our result that the expression of a mutant NBS1 proteinlacking both phosphorylation site and FHA/BRCT domain inGM7166VA cells was unable to complement not only nuclearfoci formation of the complex but also radiation resistance ofthe cells (data not shown). Therefore, we conclude that FHA/BRCT domain, possibly sole FHA domain, is essential for thenuclear foci formation of the triple-protein complex togetherwith the presence of both hMRE11-binding domain and theserine residues for phosphorylation.

A number of DNA repair-related proteins are known to form

nuclear foci in response to DNA damage, such as RAD51,BRCA1, and BLM, as well as the hRAD50zhMRE11zNBS1 com-plex (1, 8, 12, 13), and these might be affected or regulated byphosphorylation signals. In view of this, the failure of thetriple-protein complex in the FE3 and BRCT-d clones to formnuclear foci supports the putative functions of the FHA andBRCT domains, namely the FHA domain motif is for protein-protein interactions that recognize the phosphorylation state ofthe target protein (14), and the BRCT domain might provide aDNA-binding domain for repair-related proteins (15). The re-sults shown here indicate that FHA/BRCT domain is essentialfor nuclear foci formation activity following DNA damage, eventhough they are not directly related to the DNA repair abilityitself. This finding is consistent with the fact that most of theDNA double-strand breaks are rejoined within the first hourafter irradiation (16), but foci formation persists even 5–8 hafter irradiation (8, 12). Taken together, it is suggested that thenuclear foci formation is not a strict hallmark of DNA repair.Because the FHA/BRCT domain is conserved in eukaryoticNBS1 homologue, they might be involved in other crucial phe-notypes of NBS, such as in insuring the fidelity of the rejoinedDNA.

Acknowledgment—We are grateful to Dr. L. N. Kapp at University ofCalifornia, San Francisco, for editing the manuscript and Dr. S. Takedaand Dr. M. Takata at Kyoto University and Dr. N. Tsuyama at Radia-tion Effects Research Foundation, Hiroshima, Japan for helpful com-ments. We also thank Taeko Jo, Miki Ueda, Aoi Kodama, and AyaOkamoto for laboratory assistance.

REFERENCES

1. Matsuura, S., Tauchi, H., Nakamura, A., Kondo, N., Sakamoto, S., Endo, S.,Smeets, D., Solder, B., Belohradsky, B. H., Kaloustian, V. M., Oshimura,M., Isomura, M., Nakamura, Y., and Komatsu, K. (1998) Nat. Genet. 19,178–181

2. Carney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Beau, M. L., Ill, J. R. Y.,Hays, L., Morgan, W. F., and Petrini, J. H. (1998) Cell 93, 477–486

3. Varon, R., Vissinga, C., Platzer, M., Cerosaletti, K. M., Chrzanowska, K. H.,Saar, K., Beckmann, G., Seemanova, E., Cooper, P. R., Nowak, N. J.,Stumm, M., Weemaes, C. M. R., Gatti, R. A., Wilson, R. K., Digweed, M.,Rosenthal, A., Sperling, K., Concannon, P., and Reis, A. (1998) Cell 93,467–476

4. Hofman, K., and Bucher, P. (1995) Trends Biochem. Sci. 20, 347–3495. Bork, P., Hofman, K., Bucher, P., Neuwald, A., Altschul, S., and Koonin, E.

(1997) FASEB J. 11, 68–766. Harber, J. E. (1998) Cell 95, 583–3867. Trujillo, K. M., Yuan, S.-S. F., Lee, E. Y.-H. P., and Sung, P. (1998) J. Biol.

Chem. 273, 21447–214508. Ito, A., Tauchi, H., Kobayashi, J., Morishima, K., Nakamura, A., Hirokawa, Y.,

Matsuura, S., Ito, K., and Komatsu, K. (1999) Biochem. Biophys. Res.Commun. 265, 716–721

9. Lim, D.-S., Kim, S.-T., Xu, B., Maser, R. S., Lin, J., Petrini, J. H. J., andKastan, M. B. (2000) Nature 404, 613–617

10. Zhao, S., Weng, Y.-C., Yuan, S.-S. F., Lin, Y.-T., Hsu, H.-C., Lin, S.-C. J.,Gerbino, E., Song, M., Zdzienicka, M. Z., Gatti, R. A., Shay, J. W., Ziv, Y.,Shiloh, Y., and Lee, E. Y.-H. P. (2000) Nature 405, 473–477

11. Paull, T. T., and Gellert, M. (1999) Genes Dev. 13, 1276–128812. Nelms, B. E., Master, R. S., Mackay, J. F., Lagally, M. G., and Petrini, J. H. J.

(1998) Science 280, 590–59213. Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., and Qin, J. (2000) Genes

Dev. 14, 927–93914. Durocher, D., Henckel, J., Fersht, A. R., and Jackson, S. P. (1999) Mol. Cell 4,

387–39415. Yamane, K., and Turuo, T. (1999) Oncogene 18, 5194–520316. Komatu, K., Kubota, N., Gallo, M., Okumura, Y., and Lieber, M. R. (1995)

Cancer Res. 55, 1774–1779

Functional Domains of NBS1 15

by guest on July 23, 2020http://w

ww

.jbc.org/D

ownloaded from

Page 5: Accelerated Publication THE J B C · 2017-04-12 · was detected only when codons 665–693 were present in the construct even when N-terminal FHA/BRCT domains were deleted (Fig

KomatsuNakamura, Takahiro Shiraishi, Emi Ito, Debora Masnada, Domenico Delia and Kenshi

Hiroshi Tauchi, Junya Kobayashi, Ken-ichi Morishima, Shinya Matsuura, AsakoRepair Activity

after Irradiation but Not Essential for hRAD50·hMRE11·NBS1 Complex DNA The Forkhead-associated Domain of NBS1 Is Essential for Nuclear Foci Formation

doi: 10.1074/jbc.C000578200 originally published online November 2, 20002001, 276:12-15.J. Biol. Chem. 

  10.1074/jbc.C000578200Access the most updated version of this article at doi:

 Alerts:

  When a correction for this article is posted• 

When this article is cited• 

to choose from all of JBC's e-mail alertsClick here

  http://www.jbc.org/content/276/1/12.full.html#ref-list-1

This article cites 16 references, 5 of which can be accessed free at

by guest on July 23, 2020http://w

ww

.jbc.org/D

ownloaded from